Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Hikma Pharmaceuticals
Pharma
Teva, like Hikma, accuses Amarin of hoarding Vascepa ingredient
In a new lawsuit, Teva flagged Amarin’s “anti-competitive conduct to prevent and delay generic competition” to Vascepa—a fish-oil-derived heart med.
Fraiser Kansteiner
Mar 29, 2024 1:10pm
Pfizer's massive North Carolina plant hit by tornado
Jul 20, 2023 10:10am
Hikma says Amarin inked supply deals to shut out generics
Feb 23, 2023 2:20pm
FDA warns common antibiotic omoxicillin is in short supply
Oct 31, 2022 11:35am
The top 10 generic drug makers by 2021 revenue
Jul 18, 2022 3:00am
Pfizer's MPP pact will provide COVID pill to 95 countries
Mar 18, 2022 10:05am